​

Funding Round

Series C - Alto Neuroscience

Series C - Alto Neuroscience

Investment Firm

Overview

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Announced Date

Nov 21, 2023

Closed on Date

Nov 21, 2023

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

10

Investor Name
Participant InvestorAlkeon Capital
Participant InvestorWindham Venture Partners
Participant InvestorEli Lilly
Participant InvestorPoint72 Ventures
Participant InvestorFranklin Templeton

Round Details and Background

Alto Neuroscience raised $45000000 on 2023-11-21 in Series C

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 30, 2023
Debt Financing - Alto Neuroscience
1-35.0M
Jan 01, 2020
Seed Round - Alto Neuroscience
1-undefined
Nov 21, 2023
Series C - Alto Neuroscience
10-45.0M
Apr 06, 2022
Venture Round - Alto Neuroscience
-59.3M

Recent Activity

There is no recent news or activity for this profile.